Cite
HARVARD Citation
Murillo, J. et al. (n.d.). CTIM-08. A PILOT STUDY OF ABEMACICLIB WITH BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS WITH LOSS OF CDKN2A/B OR GAIN OR AMPLIFICATION OF CDK4/6. Neuro-oncology. p. vii61. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Murillo, J. et al. (n.d.). CTIM-08. A PILOT STUDY OF ABEMACICLIB WITH BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS WITH LOSS OF CDKN2A/B OR GAIN OR AMPLIFICATION OF CDK4/6. Neuro-oncology. p. vii61. [Online].